Emergency Tourniquet Market (2026 - 2033)

Emergency Tourniquet Market Summary

The global emergency tourniquet market size was valued at USD 150.0 million in 2025 and is projected to grow from USD 158.7 million in 2026 to USD 232.4 million by 2033, at a CAGR of 5.6% from 2026 to 2033. North America dominated the market, accounting for the revenue share of 46.5% in 2025. The market is driven by rising traumatic injuries, increasing demand for rapid hemorrhage control, and the growing use of tourniquets by military personnel, emergency medical services, and civilian first responders.

Source: Grand View Research, IR Documents, Primary Interviews, Paid Databases

To learn more about this report, Download Free Sample Report

To learn more about this report, Download Free Sample Report

The rising incidence of road traffic accidents, workplace injuries, falls, and violence-related trauma is driving demand for emergency tourniquets. Severe extremity bleeding requires rapid intervention to reduce the risk of hemorrhagic shock before definitive medical treatment is available. Emergency medical services, trauma centers, and first responders rely on tourniquets as part of prehospital bleeding-control protocols. This growing need for timely hemorrhage management supports the expansion of the emergency tourniquet industry.

To learn more about this report, Download Free Sample Report

To learn more about this report, Download Free Sample Report

The growing adoption of tourniquets in civilian emergency care is driving the market growth as ambulance services, police departments, firefighters, and first responders increasingly prioritize rapid bleeding control. Wider integration of tourniquets into prehospital trauma protocols is improving access to immediate hemorrhage management before patients reach hospitals. In addition, public bleeding-control training and the availability of emergency trauma kits in workplaces and public facilities are expanding civilian demand for tourniquet products.

For instance, in July 2025, the American College of Surgeons (ACS) announced that its STOP THE BLEED program had trained more than 5 million people to control severe bleeding and potentially save lives. Since its launch in 2016, the program has expanded across all 50 U.S. states and at least 141 countries, increasing public awareness and preparedness for bleeding emergencies and supporting the adoption of tourniquets in civilian emergency care.

“Reaching 5 million people trained is a testament to the power of teaching communities these critical lifesaving skills,” said Patricia L. Turner, MD, MBA, FACS, Executive Director & CEO of the ACS. “Our mission doesn’t stop at 5 million. We will continue our efforts until bleeding control training is as ubiquitous as CPR.”

“From Chicago to Ukraine and communities around the world, we’ve seen how these skills save lives - whether in mass casualty events or everyday accidents,” said Kenji Inaba, MD, FACS, FRCSC, Chair of the ACS Stop the Bleed Committee. “We plan to train millions more. We’re just getting started.”

To learn more about this report, Download Free Sample Report

Furthermore, the expansion of public bleeding-control training programs is driving the emergency tourniquet industry by increasing awareness of how to manage life-threatening bleeding before professional medical assistance arrives. Initiatives such as the American College of Surgeons’ STOP THE BLEED program encourage schools, workplaces, community organizations, and public safety personnel to learn tourniquet application techniques. These programs support demand for emergency tourniquets and bleeding-control kits across civilian settings, expanding adoption beyond military and clinical environments.

Market Dynamics

The emergency tourniquet industry is shaped by rising traumatic injuries, increasing awareness of rapid hemorrhage control, and growing adoption across military, civilian emergency medical services, and first-responder settings. Market growth is supported by public bleeding-control training programs, improvements in tourniquet design, and expanding emergency preparedness initiatives. However, product affordability, the need for proper application training, regulatory compliance, and concerns about improper use influence adoption across different end-user groups. Manufacturers are focusing on user-friendly designs, strategic distribution partnerships, and expanded access to bleeding-control kits to address these challenges and capture emerging market opportunities.

Market Concentration & Characteristics

The market demonstrates a moderate degree of innovation, primarily focused on improving application speed, ease of use, and reliability during critical bleeding emergencies. Manufacturers are developing improved windlass mechanisms, secure locking systems, durable materials, and ergonomic designs to support effective hemorrhage control. Innovation also includes compact configurations and training-oriented designs that improve usability for military personnel and civilian first responders. For instance, SAM Medical's SAM XT tourniquet uses TRUFORCE buckle technology that automatically locks at a predetermined circumferential force, helping reduce strap slack and simplify application. The product is available with metal and polymer windlass configurations, illustrating continued innovation in application mechanisms and product design.

The global market exhibits a relatively low to moderate level of merger and acquisition (M&A) activity, as competition is primarily driven by specialized medical device manufacturers and established tactical medical suppliers. Consolidation opportunities are linked to expanding trauma-care portfolios, strengthening distribution networks, and gaining access to military and emergency medical procurement channels. Strategic acquisitions within the broader emergency medical supplies sector also enable companies to expand their hemorrhage-control product offerings and geographic presence.

To learn more about this report, Download Free Sample Report

Regulatory requirements significantly influence the emergency tourniquet industry by establishing standards for product safety, quality, performance, and manufacturing practices. In the U.S., the FDA's medical device classification and applicable premarket requirements affect product commercialization, while the EU Medical Device Regulation (MDR) governs conformity assessment and market access in Europe. Compliance with these requirements increases testing, documentation, and quality-management costs, builds buyer confidence, and supports the adoption of reliable hemorrhage-control devices.

End-use concentration in the market is primarily influenced by military and defense organizations, emergency medical services (EMS), hospitals, and law enforcement agencies. Military and tactical applications represent an important demand segment due to the need for rapid hemorrhage control in combat-related injuries, while civilian demand is supported by ambulance services and trauma-care providers. Demand diversification across public safety organizations, healthcare facilities, and individual emergency preparedness users helps expand the market beyond defense applications.

Mechanism Type Insights

The windlass tourniquets (C-A-T, SAM XT, SOF T) segment dominated the market with the largest revenue share of 70.0% in 2025. due to their established use in military, tactical, and civilian trauma care. Their mechanical tightening mechanisms enable controlled application of pressure to manage life-threatening extremity bleeding. Proven product designs, portability, and familiarity among trained first responders supported demand across defense organizations and emergency medical services.

To learn more about this report, Download Free Sample Report

The elastic tourniquet segment is expected to grow at the fastest CAGR during the forecast period due to its lightweight construction, flexibility, and ease of use in selected emergencies and clinical applications. Its compact design supports convenient storage in first-aid kits and emergency medical supplies. Growing demand for portable bleeding-control solutions may create opportunities for the adoption of elastic tourniquets, although their suitability for severe hemorrhage control depends on the specific product design and intended use.

End Use Type Insights

The military & defense segment dominated the market, with the largest revenue share of 44.2% in 2025, driven by the critical need for rapid hemorrhage control in combat operations, blast injuries, and tactical emergencies. Armed forces prioritize tourniquets that offer durability, rapid application, and reliable performance under challenging field conditions. Continued procurement of individual first-aid kits and tactical trauma supplies supports demand for emergency tourniquets across military medical units and defense organizations.

The emergency medical services (EMS) and first responders segment is expected to grow at the fastest CAGR during the forecast period, as demand increases for immediate hemorrhage control at accident sites and other emergency scenes. Greater integration of tourniquets into prehospital trauma protocols is supporting adoption among paramedics, ambulance personnel, firefighters, and law enforcement officers. Expanding bleeding-control training programs and investments in emergency response capabilities are further creating opportunities for tourniquet use across civilian settings.

Regional Insights

The emergency tourniquet market in North America held the largest revenue share of 46.5% in 2025, supported by established emergency medical services, advanced trauma-care infrastructure, and strong demand from military and law enforcement agencies. The growing adoption of bleeding-control kits in schools, workplaces, and public facilities is driving civilian demand. In addition, public bleeding-control education initiatives, including the American College of Surgeons’ STOP THE BLEED program, are supporting awareness and preparedness across the region.

To learn more about this report, Download Free Sample Report

U.S. Emergency Tourniquet Market Trends

The emergency tourniquet market in the U.S. accounted for the largest revenue share in North America in 2025, driven by competition among specialized trauma-care manufacturers, product differentiation, and procurement requirements across the healthcare and public safety sectors. Demand is influenced by product affordability, ease of application, durability, and compliance with applicable medical device regulations. Established distribution networks and relationships with institutional buyers also play an important role in manufacturers’ market positioning and commercial expansion.

Europe Emergency Tourniquet Market Trends

The emergency tourniquet market in Europe is supported by established emergency medical services, hospital trauma-care networks, and continued investment in prehospital emergency response capabilities. Demand varies across countries according to healthcare procurement practices, defense requirements, and access to emergency medical equipment. Compliance with the EU Medical Device Regulation (MDR) also influences product approvals, market entry, and competition among tourniquet manufacturers.

The UK emergency tourniquet market is influenced by demand from ambulance services, trauma centers, police forces, and military medical units. Investment in prehospital trauma care and emergency response capabilities supports the use of tourniquets for managing severe limb bleeding. Market development is also shaped by NHS procurement practices, product availability, and compliance with UK medical device regulations overseen by the Medicines and Healthcare Products Agency (MHRA).

The emergency tourniquet market in France is supported by the country’s established emergency medical services, hospital trauma-care infrastructure, and military medical requirements. Demand is influenced by procurement from emergency response organizations, defense agencies, and healthcare facilities seeking reliable hemorrhage-control equipment. Compliance with European Union Medical Device Regulation (MDR) requirements and France’s medical device oversight framework also shapes product commercialization and market competition.

Asia Pacific Emergency Tourniquet Market Trends

The emergency tourniquet market in the Asia-Pacific region is supported by expanding emergency medical services, improving trauma care infrastructure, and increasing investment in healthcare systems. Demand varies across the region based on access to prehospital care, military procurement, and the availability of emergency medical supplies. Growing healthcare infrastructure in countries such as China, India, Japan, and Australia provides opportunities for manufacturers to expand distribution and address diverse clinical and emergency response needs.

The China emergency tourniquet market is influenced by the expansion of emergency medical services, investments in trauma-care infrastructure, and demand from military and public safety organizations. Domestic medical device manufacturing capabilities offer local producers opportunities to supply cost-competitive hemorrhage-control products. Market growth is also shaped by medical device registration requirements, product quality standards, and the increasing emphasis on strengthening emergency response preparedness.

Latin America Emergency Tourniquet Market Trends

The emergency tourniquet market in Latin America is influenced by the gradual development of prehospital emergency care systems, trauma treatment capabilities, and public safety infrastructure. Demand is driven by hospitals, ambulance services, law enforcement agencies, and military healthcare units that require equipment for rapid bleeding control. However, disparities in healthcare funding, uneven access to emergency medical services, and dependence on imported medical devices influence product availability and market expansion across the region. According to DATASUS data from Brazil’s Ministry of Health, external causes accounted for 30,149 deaths in 2023 and 30,010 deaths in 2024 through November. The persistently high number of fatalities highlights the need for effective emergency response measures and targeted policies to reduce deaths associated with accidents and violence.

MEA Emergency Tourniquet Market Trends

The emergency tourniquet market in the Middle East and Africa (MEA) is anticipated to grow at the fastest CAGR during the forecast period, driven by demand from military medical services, emergency response agencies, hospitals, and trauma care facilities. Investments in healthcare infrastructure and emergency preparedness across parts of the Middle East are supporting the procurement of hemorrhage-control equipment. However, limited access to advanced prehospital care, budget constraints, and uneven distribution of medical supplies across parts of Africa limit broader market penetration.

Key Emergency Tourniquet Company Insights

The emergency tourniquet industry includes key players such as North American Rescue, SAM Medical, TacMed Solutions, Safeguard Medical, and RevMedX. Competition is shaped by product reliability, ease of application, procurement by military and emergency services, and distribution capabilities. However, independently verified market share percentages for individual companies are not publicly available, making precise company-level share comparisons difficult.

Key Emergency Tourniquet Companies

The following key companies have been profiled for this study on the emergency tourniquet market.

• Sam Medical (Tri-Tech Forensics, Inc.)

• North American Rescue, LLC (Henry Schein, Inc.)

• TacMed Solutions (CNL Strategic Capital, LLC)

• RevMedX

• Safeguard Medical

• Aristeia

• Snakestaff Systems

• TMI Medical LIMITED

• LOCKLIX by CNEX

• m2 Inc. (Edgewater Technology-M2)

• Rapid Medical

• CAT Resources, LLC

• Delfi Medical Innovations Inc.

• TQ DNIPRO (PROSTIR LLC)

• SICH Medical LLC

• Golden Hour Medical, Inc.

Recent Developments

• In January 2026, Golden Hour Medical, the company behind the AutoTQ automated tourniquet, announced a collaboration with The Blueprint Corporation to expand access to advanced bleeding-control technology across safety-focused organizations in the United States. The partnership aims to improve the availability of automated hemorrhage-control solutions across civilian and professional emergency-response settings.

• In January 2026, Lee County Public Safety partnered with Golden Hour Medical, Inc. to deploy 25 AutoTQ Automatic Tourniquet kits across public parks and recreation locations in Lee County, Florida. The kits were installed alongside county-managed automated external defibrillators (AEDs), expanding public access to emergency equipment for sudden cardiac arrest and life-threatening bleeding.

• In April 2025, research led by Dr. Naveena Yanamala at Rutgers Health evaluated Auric Innovations’ XForce Tourniquet against the industry-standard Combat Application Tourniquet (C-A-T). The study, published as a preprint on medRxiv, reported that the XForce Tourniquet reduced total application time by 47% compared with the C-A-T, highlighting its potential to improve application speed and usability in emergency hemorrhage control.

Global Emergency Tourniquet Market Report Segmentation

This report forecasts revenue growth at global, regional & country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global emergency tourniquet market report based on mechanism type, end use, and region:

To learn more about this report, Download Free Sample Report

• Mechanism Type Outlook (Revenue, USD Million, 2021 - 2033)

  • Ratcheting Tourniquets

  • Windlass Tourniquets (CAT, SAM-XT, SOF T)

  • Elastic Tourniquets

  • Dial-Tightened Tourniquets

• End Use Outlook (Revenue, USD Million, 2021 - 2033)

  • Military & Defense

  • Emergency Medical Services (EMS) & First Responders

  • Consumer, Civilian & Industrial

• Regional Outlook (Revenue, USD Million, 2021 - 2033)

  • North America

    • U.S.

    • Canada

    • Mexico

  • Europe

    • UK

    • Germany

    • France

    • Italy

    • Spain

    • Denmark

    • Sweden

    • Norway

  • Asia Pacific

    • Japan

    • China

    • India

    • Thailand

    • Australia

    • South Korea

  • Latin America

    • Brazil

    • Argentina

  • Middle East & Africa

    • South Africa

    • Saudi Arabia

    • UAE

    • Kuwait

Research Methodology

The emergency tourniquet market figures in this report are based on a proven research process that combines executive interviews with secondary research from proprietary databases, company filings, and recognized regulatory and institutional sources. Market size is built through value-chain sizing - reconciling supply-side and demand-side estimates - and triangulated with bottom-up and top-down approaches. Every estimate passes multiple levels of expert validation before publication, with each emergency tourniquet segment quantified using the revenue-capture definitions in the table below.

Delivered Customizations

This report has been delivered with the following In-depth customizations